BlackRock Health Sciences Term Trust (NYSE:BMEZ) Short Interest Update

BlackRock Health Sciences Term Trust (NYSE:BMEZ) was the recipient of a significant growth in short interest in the month of February. As of February 13th, there was short interest totaling 18,985 shares, a growth of 135.3% from the January 29th total of 8,067 shares. Based on an average daily volume of 277,885 shares, the days-to-cover ratio is presently 0.1 days. Based on an average daily volume of 277,885 shares, the days-to-cover ratio is presently 0.1 days.

Insider Buying and Selling

In other BlackRock Health Sciences Term Trust news, Director Robert W. Fairbairn sold 10,294 shares of the company’s stock in a transaction on Thursday, December 18th. The shares were sold at an average price of $14.98, for a total value of $154,204.12. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.

Hedge Funds Weigh In On BlackRock Health Sciences Term Trust

Several large investors have recently made changes to their positions in BMEZ. Bank of America Corp DE grew its position in BlackRock Health Sciences Term Trust by 4.1% during the third quarter. Bank of America Corp DE now owns 1,535,091 shares of the company’s stock valued at $22,136,000 after buying an additional 61,105 shares during the period. Penserra Capital Management LLC grew its position in shares of BlackRock Health Sciences Term Trust by 15.2% during the 3rd quarter. Penserra Capital Management LLC now owns 1,332,633 shares of the company’s stock valued at $19,216,000 after acquiring an additional 175,629 shares during the period. Invesco Ltd. grew its position in shares of BlackRock Health Sciences Term Trust by 42.7% during the 3rd quarter. Invesco Ltd. now owns 929,121 shares of the company’s stock valued at $13,398,000 after acquiring an additional 278,024 shares during the period. Rivernorth Capital Management LLC raised its holdings in BlackRock Health Sciences Term Trust by 195.8% in the 4th quarter. Rivernorth Capital Management LLC now owns 648,567 shares of the company’s stock worth $9,761,000 after purchasing an additional 429,291 shares during the period. Finally, Wolverine Asset Management LLC grew its holdings in BlackRock Health Sciences Term Trust by 78.8% in the fourth quarter. Wolverine Asset Management LLC now owns 401,511 shares of the company’s stock valued at $6,043,000 after purchasing an additional 176,993 shares during the period.

BlackRock Health Sciences Term Trust Price Performance

Shares of BMEZ stock opened at $15.08 on Friday. BlackRock Health Sciences Term Trust has a 52-week low of $12.58 and a 52-week high of $16.00. The business has a 50-day simple moving average of $15.20 and a 200-day simple moving average of $14.88.

BlackRock Health Sciences Term Trust Announces Dividend

The company also recently disclosed a monthly dividend, which will be paid on Tuesday, March 31st. Stockholders of record on Friday, March 13th will be paid a dividend of $0.11 per share. The ex-dividend date of this dividend is Friday, March 13th. This represents a c) dividend on an annualized basis and a dividend yield of 8.8%.

About BlackRock Health Sciences Term Trust

BlackRock Health Sciences Term Trust (NYSE: BMEZ) is a closed-end management investment company organized as a Delaware statutory trust. Launched in March 2020, BMEZ seeks to provide total return through a combination of current income and capital appreciation by investing primarily in equity and equity-related securities of companies in the health sciences sector. The trust is structured with a fixed termination date in October 2030, at which time shareholders will vote on its liquidation, extension or conversion.

The fund’s investment portfolio is diversified across subsectors within health sciences, including biotechnology, pharmaceuticals, medical devices, diagnostics and healthcare services.